Ticker Symbol: REDIF
Redhill Biopharma
Exchange: US OTC
Country:
IL
Currency:
USD
Asset
Type: Common Stock
CIK:0001553846
Company Profile
RedHill Biopharma Ltd. is a biopharmaceutical company focusing on the development and commercialization of proprietary drugs for the treatment of gastrointestinal diseases. It operates through the Commercial Operations segment and the Research & Development segment. The Commercial Operations segment covers all areas relating to the commercial sales and operating expenses directly related to that activity and is being performed by the Company’s subsidiary in the United States. The Research & Development segment includes all activities related to the research and development of therapeutic candidates. The company was founded by Dror Ben-Asher and Ori Shilo on August 3, 2009 and is headquartered in Tel Aviv, Israel.
Sector: Health Technology
Industry: Pharmaceuticals: Major
Standard Industrial Classification Code (SIC code): 2834
Address: 21 Ha'arba'a Street
Website: http://www.redhillbio.com
CEO: Dror Ben-Asher
Tags:
- Biotechnology
- Health Technology
- Pharmaceuticals: Major
Pricing
Last Updated: December 31, 1969 07:00 PM EST
Previous Close: -
Change:
-
(
0.00%)
Days Range: $0.67 - $0.67
Beta: -
52wk. High: -
52wk. Low: -
Ytd. Change 0.00%
50 Day Moving Average: -
200 Day Moving Average: -
Shares Outstanding: 352695668
Valuation
Market Cap: 12.7B
PE Ratio: -
EPS (TTM): 0
Dividends
Dividend Per Share (TTM): -
Dividend Yield (TTM): 0.00%
Ex-Dividend Date: N/A